Brainstorm Cell Therapeutics In

Q2 2024 13F Holders

Symbol
BCLI
CUSIP
10501E201
Type
Equity
Class
COM NEW
Num filings
55
Total reported value, excl. options
$4.10 M
Manager Report Date Value ($000) Shares Option Type